Skip to Content

C223 (Alendronate Sodium 35 mg)

Pill with imprint C223 is White, Capsule-shape and has been identified as Alendronate Sodium 35 mg. It is supplied by Cipla USA Inc..

Alendronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C223

Alendronate sodium 35 mg C223

Alendronate Sodium

Imprint
C223
Strength
35 mg
Color
White
Size
10.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Bisphosphonates
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0223
Inactive Ingredients
mannitol, microcrystalline cellulose, sodium starch glycolate type A potato, corn starch, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "C223"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.